25
FEB

Introduction to Cost Effectiveness Analysis

February 25, 2026

11:30 AM

About this Event

Course 3 of 4 SMDM Core Courses

Join course faculty Jeffrey Hoch, PhD, and Mark Bounthavong, PhD, as they lead you through an introduction to cost-effectiveness analysis.

Cost-effectiveness analysis (CEA) is the most popular type of economic evaluation. CEA produces estimates of the extra cost and patient outcomes when one or more new treatments are compared to usual care. CEA is often required by public payers internationally and is often the subject of presentations, posters, and papers in academic settings.

Through theory bursts followed by interactive exercises, the course will answer the WHO, WHERE, WHY, WHEN, WHAT, HOW questions related to CEA. Given the introductory level, this class is for individuals interested in developing their understanding of SMDM posters and presentations. Our objective is that attendees will be able to explain more confidently what presenters have done, what they have found and what it means. We will practice identifying meaningful knowledge being conveyed in the four languages: Plain language, Math, Graph, and Jargon. In addition, attendees will complete this class with the confidence to engage more thoroughly with the producers of economic evaluations meant to inform medical decision making. Lastly, we will review guidance documents featuring “best practices” for doing CEA.

This core course is 3.5 hours, rather than 4 hours.

About the Faculty:

Jeffrey Hoch, PhD,  is the Chief of the Division of Health Policy and Management in the Department of Public Health Sciences at the University of California at Davis. Also, he is the Associate Director of the Center for Healthcare Policy and Research at UC Davis. An award-winning teacher, Professor Hoch has taught Health Economics and Economic Evaluation classes throughout the world. Professor Hoch pursues research making health economics more useful to decision makers.

Mark Bounthavong, Pharm.D., PhD, MPH is an Associate Professor of Clinical Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego. His research interests include pharmacoeconomics, program and implementation evaluations, applied econometrics, and evidence-synthesis using Bayesian methods. More recently, Dr. Bounthavong’s research has centered around evaluating academic detailing’s impact on aligning provider’s behavior with evidence-based practice, particularly with the opioid epidemic.

Register for this course, or the entire Core Course series, here!